NCHR urges FDA to require more diversity in trials to improve accuracy of pulse ox devices

December 2, 2022: NCHR testified at an FDA meeting that there is strong evidence that commonly-used pulse oximeters are less reliable for patients with pigmented skin. The FDA’s current guidelines do not require product labeling to address the impact of skin pigmentation on pulse oximetry. While labeling is important to alert users to possible inaccuracies, it does not diminish the importance of developing devices that are effective for everyone.

Read More »

Liver Cancer: What is it and how to prevent it

This article explains the signs and symptoms of liver cancer and the steps you can take to prevent it. The best way to prevent it is to be tested for Hepatitis C, get vaccinated for Hepatitis B, and if diagnosed with either, get treated. Reducing smoking and alcohol consumption also helps prevent liver cancer.

Read More »

Treating Prostate Cancer: Options to Consider

Men who are diagnosed with prostate cancer are faced with the difficult decision of deciding what to do next, since treatment is not always necessary, and each treatment option has advantages and disadvantages. The more that patients understand about the options, the more likely that they will make the decision that is right for them. That is the goal of this article.

Read More »